Clinical Screening Tool

EDES-P

Paediatric Endocrine Disruptor Exposure Screen

The EDES-P is a clinician-guided exposure screening tool developed specifically for paediatric populations across three distinct developmental stages: infancy and early childhood (0–3 years), childhood (3–8 years), and adolescence (9–18 years). Each sub-tool is tailored to the exposure profile, caregiver context, and developmental vulnerabilities most relevant to its stage.

Version v3 | Last updated: June 2026

Why screening for EDC exposure matters in paediatric care

Children are not simply small adults. They pass through a series of tightly programmed developmental windows — neonatal, early childhood, and pubertal — during which hormone-dependent processes unfold within narrow biological timeframes. EDC exposure during these windows can cause qualitatively different effects than in adults, disrupting developmental trajectories in ways that may not become clinically apparent until years or decades later.

Children are also significantly less able to clear environmental toxicants. The hepatic detoxification systems responsible for metabolising EDCs are immature across early childhood and are not adult-equivalent until well into adolescence. Combined with higher relative surface area, faster respiratory rates, and greater hand-to-mouth activity in younger children, this creates a substantially amplified biological burden for any given level of exposure.

The EDES-P gives clinicians a practical, structured tool to identify the exposure domains most relevant to a child’s developmental stage — and to open family-centred conversations that can meaningfully reduce that burden.

Clinical disclaimer: EDES tools are educational screening instruments designed to support structured clinical conversations about environmental chemical exposure. They are not diagnostic tools, do not replace clinical judgement, and are not formal clinical guidelines.

Ages 0–3

EDES-P (Infancy)

Why EDC exposure screening is particularly important in infancy

Infancy is the period of highest biological vulnerability across the entire lifespan. The first three years encompass rapid brain development, hypothalamic-pituitary axis establishment, immune programming, gut microbiome formation, and metabolic architecture — all acutely sensitive to hormonal disruption.

The EDES-P Infancy screen focuses on caregiver habits and the home environment — the domains where meaningful change is most achievable — and is designed to support a brief, non-alarmist, practical conversation with parents or primary caregivers.

Who this sub-tool is for

  • Paediatric well-child consultations from birth to 3 years
  • Postpartum and breastfeeding consultations where infant exposure is a relevant concern
  • Family medicine consultations with a preventive health focus
  • Integrative or functional paediatric practice
  • Any consultation where a caregiver raises concern about household chemical exposures

EDES-P (Infancy) Package

EDES-P Infancy Clinical Tool

Printer-ready questionnaire for caregiver completion

EDES-P Infancy Interpretation Guide

Scoring, domain flag logic, developmental context, and counselling priorities

EDES-P Infancy Caregiver Handout

Practical guide to reducing infant EDC exposure

EDES-P Infancy Lactation Handout

Guidance for breastfeeding mothers on EDC exposure

Ages 3–8

EDES-P (Child)

Why EDC exposure screening is particularly important in childhood

The childhood years represent a period of continued neurological development, immune maturation, and early metabolic patterning. Childhood is when EDC exposures accumulate quietly, building a body burden that will interact with the hormonal surges of puberty and reproductive development later.

Children in this age group have a broader and less caregiver-controlled exposure landscape. The EDES-P Child screen builds a practical exposure picture across home, dietary, and school domains to guide targeted, family-centred counselling.

Who this sub-tool is for

  • Paediatric consultations for children aged 3–8
  • School-age health assessments with a preventive or lifestyle focus
  • Family medicine consultations where a parent raises concern about hormonal or developmental health
  • Integrative paediatric practice
  • Any consultation where precocious puberty, growth concerns, or neurodevelopmental issues are under discussion

EDES-P (Child) Package

EDES-P Child Clinical Tool

Printer-ready questionnaire for caregiver and child completion

EDES-P Child Interpretation Guide

Scoring, domain flag logic, and age-relevant counselling priorities

EDES-P Child Family Handout

Practical guide to reducing childhood EDC exposure

Ages 9–18

EDES-P (Adolescent)

Why EDC exposure screening is particularly important in adolescence

Adolescence is the second critical developmental window — after the foetal and early neonatal period — during which the endocrine system undergoes defining, largely irreversible programming. The hormonal events of puberty establish the architecture of adult reproductive function, bone density, body composition, immune regulation, and metabolic set points.

Epidemiological literature has associated EDC exposure during adolescence with earlier menarche, altered pubertal timing, disrupted ovarian reserve, impaired spermatogenesis, increased risk of hormone-sensitive cancers, and long-term metabolic and thyroid dysfunction. The EDES-P Adolescent screen is designed to be completed directly with the young person — in an age-appropriate, non-alarmist, empowering frame.

Who this sub-tool is for

  • Adolescent health consultations for patients aged 9–18
  • Puberty-related consultations: delayed or precocious puberty, cycle irregularity, heavy periods
  • Adolescent reproductive health assessments
  • Consultations where thyroid function, acne, weight, or mood are concerns with a hormonal component
  • Preventive health for adolescents with a family history of PCOS, endometriosis, or thyroid disease
  • Integrative or functional paediatric / adolescent practice

EDES-P (Adolescent) Package

EDES-P Adolescent Clinical Tool

Designed for direct adolescent completion with accessible language

EDES-P Adolescent Interpretation Guide

Scoring, domain flag logic, and puberty-stage context

EDES-P Adolescent Teen Handout

Empowering guide to reducing personal EDC exposure

EDES-P Adolescent Feminine Care Handout

Guidance on menstrual products and intimate care for adolescent females

Stay informed of tool updates

Register to receive notifications when new versions, scoring revisions, or updated clinical guidelines are released.

Notify me about updates to:

Your data is used solely for tool update notifications and is never shared with third parties. You can unsubscribe at any time.

Evidence Note

Grounded in peer-reviewed endocrinology, reproductive toxicology, and developmental biology literature.

Visit the Evidence Base

Implementation Support

Patient-facing handouts, counselling guides, and expanded clinical education materials.

Visit Endocrine Resilience

Expert Feedback

We welcome feedback on domains, clinical language, and practical usability.

Submit feedback